MYR Group Inc. to Attend Stifel 2026 Boston Cross Sector 1x1 Conference in June

Priority Technology Holdings, Inc. To Announce First Quarter 2026 Financial Results on May 11, 2026

Aviat Networks Announces Fiscal 2026 Third Quarter and Nine Month Financial Results

Capricor Therapeutics to Report First Quarter 2026 Financial Results and Provide Recent Corporate Update on May 12

Biohaven Reports Recent Business Developments and First Quarter 2026 Financial Results

Inspire Medical Systems, Inc. Announces First Quarter 2026 Financial Results and Updates 2026 Guidance

CPS Technologies Corp. Announces Hiring of New Chief Financial Officer

Duolingo Reports First Quarter 2026 Results

Biodesix Announces First Quarter 2026 Results and Highlights

CPS Technologies Announces First Quarter 2026 Financial Results

Praxis Precision Medicines to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026, and Participate in Upcoming Investor Conference

FibroBiologics Reports Preclinical Data Showing Fibroblast Spheroids May Actively Reprogram the Burn Wound Environment to Drive Healing and Reduce Scarring

Senseonics Announces Closing of $92 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Diamondback Energy, Inc. Announces First Quarter 2026 Financial and Operating Results; Increases Base Dividend and Production Guidance

Ocugen Announces Private Offering of $115 Million of Convertible Senior Notes

Dorman Products, Inc. Reports First Quarter 2026 Results and Reaffirms 2026 Guidance

Meridian Corporation Reports Revised First Quarter 2026 Results

PARAMOUNT REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS

Viper Energy, Inc., a Subsidiary of Diamondback Energy, Inc., Reports First Quarter 2026 Financial and Operating Results

Cytokinetics to Announce Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy, on May 5, 2026